Common Contracts
31 similar null contracts by Tapestry, Inc., Avinger Inc, Brighthouse Financial, Inc., others
TAPESTRY, INC. as the Company and U.S. BANK NATIONAL ASSOCIATION as the TrusteeTapestry, Inc. • November 27th, 2023 • Leather & leather products • New York
INDENTURE, dated as of December 1, 2021, between Tapestry, Inc., a Maryland corporation as the Company (the “Company”), and U.S. Bank National Association, as trustee (the “Trustee”).
HOTH THERAPEUTICS, INC., ISSUER AND [TRUSTEE], TRUSTEE INDENTURE DATED AS OF , 20 SUBORDINATED DEBT SECURITIESHoth Therapeutics, Inc. • June 13th, 2023 • Pharmaceutical preparations • New York
WHEREAS, for its lawful corporate purposes, the Company has duly authorized the execution and delivery of this Indenture to provide for the issuance of subordinated debt securities (hereinafter referred to as the “Securities”), in an unlimited aggregate principal amount to be issued from time to time in one or more series as in this Indenture provided, as registered Securities without coupons, to be authenticated by the certificate of the Trustee;
TIAN RUIXIANG HOLDINGS LTD (the “Issuer”) AND [TRUSTEE] (the “Trustee”) INDENTURE Dated as of [●], 20[●] Subordinated Debt SecuritiesTian Ruixiang Holdings LTD • January 20th, 2023 • Insurance agents, brokers & service • New York
INDENTURE, dated as of [●], 20[●], among TIAN RUIXIANG Holdings Ltd, a Cayman Islands company (the “Company”), and [TRUSTEE], as trustee (the “Trustee”).
TIAN RUIXIANG HOLDINGS LTD (the “Issuer”) AND [TRUSTEE] (the “Trustee”) INDENTURE Dated as of [●], 20[●] Senior Debt SecuritiesTian Ruixiang Holdings LTD • January 20th, 2023 • Insurance agents, brokers & service • New York
INDENTURE, dated as of [●], 20[●], among TIAN RUIXIANG Holdings Ltd, a Cayman Islands company (the “Company”), and [TRUSTEE], as trustee (the “Trustee”).
AVINGER, INC., Issuer AND [TRUSTEE], TrusteeAvinger Inc • March 29th, 2022 • Surgical & medical instruments & apparatus • New York
Whereas, for its lawful corporate purposes, the Company has duly authorized the execution and delivery of this Indenture to provide for the issuance of subordinated debt securities (hereinafter referred to as the “Securities”), in an unlimited aggregate principal amount to be issued from time to time in one or more series as in this Indenture provided, as registered Securities without coupons, to be authenticated by the certificate of the Trustee;
AVINGER, INC., Issuer AND [TRUSTEE], TrusteeAvinger Inc • March 29th, 2022 • Surgical & medical instruments & apparatus • New York
Whereas, for its lawful corporate purposes, the Company has duly authorized the execution and delivery of this Indenture to provide for the issuance of debt securities (hereinafter referred to as the “Securities”), in an unlimited aggregate principal amount to be issued from time to time in one or more series as in this Indenture provided, as registered Securities without coupons, to be authenticated by the certificate of the Trustee;
GTY TECHNOLOGY HOLDINGS INC., Issuer AND [TRUSTEE], Trustee SUBORDINATED INDENTURE Dated as of [•], 20[•]GTY Technology Holdings Inc. • January 21st, 2022 • Services-computer processing & data preparation • New York
SUBORDINATED INDENTURE, dated as of [•], 20[•], among GTY TECHNOLOGY HOLDINGS INC., a Massachusetts corporation (the “Company”), and [ TRUSTEE ], as trustee (the “Trustee”):
TAPESTRY, INC. as the Company and U.S. BANK NATIONAL ASSOCIATION as the TrusteeTapestry, Inc. • December 1st, 2021 • Leather & leather products • New York
INDENTURE, dated as of December 1, 2021, between Tapestry, Inc., a Maryland corporation as the Company (the “Company”), and U.S. Bank National Association, as trustee (the “Trustee”).
AYTU BIOPHARMA, INC. Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of _______, 20__ Debt SecuritiesAytu Biopharma, Inc • September 28th, 2021 • Pharmaceutical preparations • New York
WHEREAS, for its lawful corporate purposes, the Company has duly authorized the execution and delivery of this Indenture to provide for the issuance of debt securities (hereinafter referred to as the “Securities”), in an unlimited aggregate principal amount to be issued from time to time in one or more series as in this Indenture provided, as registered Securities without coupons, to be authenticated by the certificate of the Trustee;
AKERO THERAPEUTICS, INC., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [●], 202[●] Subordinated Debt SecuritiesAkero Therapeutics, Inc. • May 18th, 2021 • Pharmaceutical preparations • New York
INDENTURE, dated as of [●], 202[●] , among AKERO THERAPEUTICS, INC.., a Delaware corporation (the “Company”), and [TRUSTEE] as trustee (the “Trustee”):
TAPESTRY, INC. as the Company and U.S. BANK NATIONAL ASSOCIATION as the TrusteeTapestry, Inc. • February 12th, 2021 • Leather & leather products • New York
INDENTURE, dated as of , between Tapestry, Inc., a Maryland corporation as the Company (the “Company”), and U.S. Bank National Association, as trustee (the “Trustee”).
GTY TECHNOLOGY HOLDINGS INC., Issuer AND [TRUSTEE], Trustee SUBORDINATED INDENTURE Dated as of [•], 20[•]GTY Technology Holdings Inc. • November 18th, 2020 • Services-computer processing & data preparation • New York
SUBORDINATED INDENTURE, dated as of [•], 20[•], among GTY TECHNOLOGY HOLDINGS INC., a Massachusetts corporation (the “Company”), and [ TRUSTEE ], as trustee (the “Trustee”):
INDENTURE Dated as of [•], 20__ Debt SecuritiesSI-BONE, Inc. • November 13th, 2019 • Surgical & medical instruments & apparatus • New York
WHEREAS, for its lawful corporate purposes, the Company has duly authorized the execution and delivery of this Indenture to provide for the issuance of debt securities (hereinafter referred to as the “Securities”), in an unlimited aggregate principal amount to be issued from time to time in one or more series as in this Indenture provided, as registered Securities without coupons, to be authenticated by the certificate of the Trustee;
GENMARK DIAGNOSTICS, INC., ISSUER AND [TRUSTEE], TRUSTEE INDENTURE DATED AS OF , 20 SENIOR DEBT SECURITIESGenMark Diagnostics, Inc. • November 20th, 2018 • Surgical & medical instruments & apparatus • New York
Page ARTICLE I DEFINITIONS Section 1.01 Definitions of Terms 2 ARTICLE II ISSUE, DESCRIPTION, TERMS, EXECUTION, REGISTRATION AND EXCHANGE OF SECURITIES 5 Section 2.01 Designation and Terms of Securities 5 Section 2.02 Form of Securities and Trustee’s Certificate 6 Section 2.03 Denominations: Provisions for Payment 7 Section 2.04 Execution and Authentications 8 Section 2.05 Registration of Transfer and Exchange 8 Section 2.06 Temporary Securities 10 Section 2.07 Mutilated, Destroyed, Lost or Stolen Securities 10 Section 2.08 Cancellation 10 Section 2.09 Benefits of Indenture 11 Section 2.10 Authenticating Agent 11 Section 2.11 Global Securities 11 ARTICLE III REDEMPTION OF SECURITIES AND SINKING FUND PROVISIONS 13 Section 3.01 Redemption 13 Section 3.02 Notice of Redemption 13 Section 3.03 Payment Upon Redemption 13 Section 3.04 Sinking Fund 14 Section 3.05 Satisfaction of Sinking Fund Payments with Securities 14 Section 3.06 Redemption of Securities for Sinking Fund 14 ARTICLE IV COVEN
BRIGHTHOUSE FINANCIAL, INC., as Issuer AND U.S. BANK NATIONAL ASSOCIATION, as Trustee JUNIOR SUBORDINATED INDENTURE DATED AS OF SEPTEMBER 12, 2018 PROVIDING FOR ISSUANCE OF JUNIOR SUBORDINATED DEBT SECURITIES IN SERIESBrighthouse Financial, Inc. • September 12th, 2018 • Life insurance • New York
JUNIOR SUBORDINATED INDENTURE, dated as of September 12, 2018, between Brighthouse Financial, Inc., a Delaware corporation, and U.S. Bank National Association, a national banking association, as Trustee.
BRIGHTHOUSE FINANCIAL, INC., as Issuer AND U.S. BANK NATIONAL ASSOCIATION, as Trustee JUNIOR SUBORDINATED INDENTURE DATED AS OF [•] PROVIDING FOR ISSUANCE OF JUNIOR SUBORDINATED DEBT SECURITIES IN SERIESBrighthouse Financial, Inc. • September 5th, 2018 • Life insurance • New York
JUNIOR SUBORDINATED INDENTURE, dated as of [•], between Brighthouse Financial, Inc., a Delaware corporation, and U.S. Bank National Association, a national banking association, as Trustee.
ORGENESIS INC.,Orgenesis Inc. • March 19th, 2018 • Pharmaceutical preparations • New York
TAPESTRY, INC. as the Company and U.S. BANK NATIONAL ASSOCIATION as the TrusteeTapestry, Inc. • February 7th, 2018 • Leather & leather products • New York
INDENTURE, dated as of , between Tapestry, Inc., a Maryland corporation as the Company (the “Company”), and U.S. Bank National Association, as trustee (the “Trustee”).
MAXWELL TECHNOLOGIES, INC. ISSUER AND [TRUSTEE], TRUSTEE INDENTURE DATED AS OF , 20 SENIOR DEBT SECURITIESMaxwell Technologies Inc • November 9th, 2017 • Miscellaneous electrical machinery, equipment & supplies • New York
RA PHARMACEUTICALS, INC. Issuer AND AMERICAN STOCK TRANSFER & TRUST COMPANY, LLC, TrusteeRa Pharmaceuticals, Inc. • November 1st, 2017 • Pharmaceutical preparations • New York
INDENTURE, dated as of [·], among RA PHARMACEUTICALS, INC., a Delaware corporation (the “Company”), and AMERICAN STOCK TRANSFER & TRUST COMPANY, LLC, as trustee (the “Trustee”):
HALOZYME THERAPEUTICS, INC., ISSUER AND [TRUSTEE], TRUSTEE INDENTURE DATED AS OF , 20 SENIOR DEBT SECURITIESHalozyme Therapeutics Inc • February 28th, 2017 • Biological products, (no disgnostic substances) • New York
Page ARTICLE I DEFINITIONS 1 Section 1.1 Definitions of Terms 1 ARTICLE II ISSUE, DESCRIPTION, TERMS, EXECUTION, REGISTRATION AND EXCHANGE OF SECURITIES 4 Section 2.1 Designation and Terms of Securities 4 Section 2.2 Form of Securities and Trustee’s Certificate 5 Section 2.3 Denominations: Provisions for Payment 5 Section 2.4 Execution and Authentications 6 Section 2.5 Registration of Transfer and Exchange 7 Section 2.6 Temporary Securities 8 Section 2.7 Mutilated, Destroyed, Lost or Stolen Securities 8 Section 2.8 Cancellation 9 Section 2.9 Benefits of Indenture 9 Section 2.10 Authenticating Agent 9 Section 2.11 Global Securities 9 ARTICLE III REDEMPTION OF SECURITIES AND SINKING FUND PROVISIONS 10 Section 3.1 Redemption 10 Section 3.2 Notice of Redemption 10 Section 3.3 Payment Upon Redemption 11 Section 3.4 Sinking Fund 11 Section 3.5 Satisfaction of Sinking Fund Payments with Securities 12 Section 3.6 Redemption of Securities for Sinking Fund 12 ARTICLE IV COVENANTS 12 Section 4.1
LONG ISLAND ICED TEA CORP., As Issuer, AND As Trustee INDENTURE DATED AS OF [__________] [___], 20[__] SENIOR DEBT SECURITIES CROSS-REFERENCE TABLE (1)Long Island Iced Tea Corp. • September 30th, 2016 • Beverages • New York
WHEREAS, for its lawful corporate purposes, the Company has duly authorized the execution and delivery of this Indenture to provide for the issuance of debt securities (hereinafter referred to as the “Securities”), in an unlimited aggregate principal amount to be issued from time to time in one or more series as provided in this Indenture, as registered Securities without coupons, to be authenticated by the certificate of the Trustee;
CHINA AUTOMOTIVE SYSTEMS, INC., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [—], 20[—] Subordinated Debt SecuritiesChina Automotive Systems Inc • May 22nd, 2015 • Motor vehicle parts & accessories • New York
MAST THERAPEUTICS, INC., ISSUER AND [TRUSTEE], TRUSTEE INDENTURE DATED AS OF , 20 SUBORDINATED DEBT SECURITIESMast Therapeutics, Inc. • March 24th, 2015 • Pharmaceutical preparations • New York
INDENTURE, dated as of [—], 20[—], among MAST THERAPEUTICS, INC., a Delaware corporation (the “Company”), and [TRUSTEE], as trustee (the “Trustee”):
ORGANOVO HOLDINGS, INC., ISSUER AND [TRUSTEE], TRUSTEE INDENTURE DATED AS OF , 20 SUBORDINATED DEBT SECURITIESOrganovo Holdings, Inc. • February 27th, 2015 • Biological products, (no disgnostic substances) • New York
INDENTURE, dated as of [•], 200 , among Organovo Holdings, INC., a Delaware corporation (the “Company”), and [TRUSTEE], as trustee (the “Trustee”):
ORGANOVO HOLDINGS, INC., ISSUER AND [TRUSTEE], TRUSTEE INDENTURE DATED AS OF , 20 SENIOR DEBT SECURITIESOrganovo Holdings, Inc. • February 27th, 2015 • Biological products, (no disgnostic substances) • New York
INDENTURE, dated as of [•], 20[•], among Organovo Holdings, Inc., a Delaware corporation (the “Company”), and [TRUSTEE], as trustee (the “Trustee”):
TD AMERITRADE HOLDING CORPORATION, as IssuerTd Ameritrade Holding Corp • October 23rd, 2014 • Security brokers, dealers & flotation companies • New York
INDENTURE, dated as of October 22, 2014, among TD AMERITRADE HOLDING CORPORATION, a Delaware corporation (the “Company”) and U.S. BANK NATIONAL ASSOCIATION, a national banking association duly incorporated and existing under the laws of the United States of America (the “Trustee”).
DOMINION GAS HOLDINGS, LLC, ISSUER to DEUTSCHE BANK TRUST COMPANY AMERICAS, TRUSTEE JUNIOR SUBORDINATED INDENTURE DATED AS OF JUNIOR SUBORDINATED NOTESDominion Resources Inc /Va/ • July 3rd, 2014 • Electric services • New York
THIS JUNIOR SUBORDINATED INDENTURE (the “Indenture”), dated as of the 1st day of , between DOMINION GAS HOLDINGS, LLC, a limited liability company duly organized and existing under the laws of the Commonwealth of Virginia (hereinafter sometimes referred to as the “Company”), having its principal executive office located at 120 Tredegar Street, Richmond, Virginia 23219 and DEUTSCHE BANK TRUST COMPANY AMERICAS, a New York banking corporation, duly organized and existing under the laws of the State of New York (hereinafter called the “Trustee”), having its Corporate Trust Office located at 60 Wall Street, 16th Floor, New York, New York 10005.
ICO GLOBAL COMMUNICATIONS (HOLDINGS) LIMITED, ISSUER AND [TRUSTEE], TRUSTEEICO Global Communications (Holdings) LTD • July 3rd, 2008 • Radio & tv broadcasting & communications equipment • New York
INDENTURE, dated as of [·], 20__, among ICO Global Communications (Holdings) Limited a Delaware corporation (the “Company”), and [TRUSTEE], as trustee (the “Trustee”):
INDENTURE BETWEEN PHARMACOPEIA, INC. AND AS TRUSTEE DATED AS OF , 200Pharmacopeia Drug Discovery Inc • August 13th, 2007 • Services-commercial physical & biological research • New York
INDENTURE, dated as of , between PHARMACOPEIA, INC., a Delaware corporation (the “Company”), having its principal office at , and , as trustee, (the “Trustee”), the office of the Trustee at which at the date hereof its corporate trust business is principally administered being .
